Are We Competing or Failing Together? Rethinking Global Access for Precision Medicine
- How bold, strategic collaborations between regulators, diagnostics, Association and pharma can unlock global patient access to IVD
- Why compliance and market-shaping access solutions must evolve to match the ambition of precision medicine
- The urgent need to redefine our competitive mindset – from siloed wins to shared impact